Search Medical Condition
Please enter condition
Please choose location from dropdown

Katy, Texas Clinical Trials

A listing of Katy, Texas clinical trials actively recruiting patient volunteers.

RESULTS

Found (48) clinical trials

Observational Study of Characteristics Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)

The CHRONICLE Study is a multi-center, non-interventional, prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and/or require systemic corticosteroid or monoclonal antibody therapy. This study will provide a contemporary description of the epidemiology and medical management of United ...

Phase N/A

6.18 miles

Learn More »

A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)

This is a randomized, placebo-controlled, parallel-group, multi-center, double-blind, event driven study of vericiguat (MK-1242) in participants with HFrEF. The primary hypothesis is vericiguat (MK-1242) is superior to placebo in increasing the time to first occurrence of the composite of cardiovascular (CV) death or heart failure (HF) hospitalization in participants with ...

Phase

6.9 miles

Learn More »

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

To determine whether treatment with sacubitril/valsartan provides a superior effect on aortic characteristic impedance compared to enalapril in patients with heart failure and reduced ejection fraction (left ventricular ejection fraction [LVEF] 40%) after 12 weeks of treatment. The primary endpoint is the change in aortic characteristic impedance (Zc = dP/dQ ...

Phase

6.9 miles

Learn More »

Pembrolizumab Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Ovarian Primary Peritoneal or Fallopian Tube Cancer

PRIMARY OBJECTIVES: I. To evaluate progression-free survival of paclitaxel/carboplatin and pembrolizumab in patients with advanced stage, metastatic ovarian cancer undergoing neoadjuvant chemotherapy (NACT). SECONDARY OBJECTIVES: I. To describe the feasibility of combination therapy and maintenance pembrolizumab in this population. II. To evaluate the safety of combination and maintenance pembrolizumab. III. ...

Phase

6.9 miles

Learn More »

Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer

Study Groups: If you are found to be eligible to take part in this study, you will be assigned to either the Safety Lead-in or the Phase 2 portion. The study group you are in will depend on when you join the study. In the Safety Lead-in, each study cycle ...

Phase

6.9 miles

Learn More »

A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma

Study Drug Administration: The day of your first dose of pemetrexed: You will start a vitamin pill (folic acid). You will continue to take folic acid every day by mouth while you are receiving pemetrexed. Folic acid has been found to decrease some of the side effects of pemetrexed. You ...

Phase

6.9 miles

Learn More »

Combining Abraxane With Capecitabine and Radiation Therapy for Consolidation of Treatment Following Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Study Groups: If you are found to be eligible to take part in this study, you will be assigned to a dose level of nab-paclitaxel based on when you join this study. Up to 3 dose levels of nab-paclitaxel will be tested. About 3-6 participants will be enrolled at each ...

Phase

6.9 miles

Learn More »

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

PRIMARY OBJECTIVES: I. Assess whether a combination of all-trans retinoic acid (ATRA [tretinoin]), and arsenic trioxide (ATO) can produce long-term event-free survival in patients with low-risk untreated acute promyelocytic leukemia (APL). II. Assess whether administration of gemtuzumab ozogamicin (GO) at the diagnosis in patients with high-risk APL (white blood cell ...

Phase

6.9 miles

Learn More »

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Kaposiform hemangioendotheliomas (KHE) are extremely rare life threatening tumors which can be associated with Kasabach-Merritt Phenomenon consisting of profound thrombocytopenia and hypofibrinogenemia causing a significant risk of bleeding and an associated mortality rate as high as 20% to 30%. Despite the severity of potential complications, we lack uniform guidelines for ...

Phase

6.9 miles

Learn More »

Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian Fallopian Tube or Primary Peritoneal Cancer

PRIMARY OBJECTIVES: I. To evaluate the safety of administration of paclitaxel, bevacizumab and emactuzumab over 4 weeks. (Part 1) II. To compare the progression-free survival (PFS) of patients with stable disease following Part 2A randomized to paclitaxel plus bevacizumab or to paclitaxel, bevacizumab plus emactuzumab. (Part 2B) SECONDARY OBJECTIVES: I. ...

Phase

6.9 miles

Learn More »